Viewing Study NCT02382406


Ignite Creation Date: 2025-12-26 @ 2:42 PM
Ignite Modification Date: 2026-02-09 @ 7:03 AM
Study NCT ID: NCT02382406
Status: TERMINATED
Last Update Posted: 2023-05-23
First Post: 2015-02-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Sponsor:
Organization: